Eptapirone

From WikiMD's Wellnesspedia

Eptapirone


Eptapirone is a potent and highly selective 5-HT1A receptor full agonist of the azapirone chemical class. It is an anxiolytic drug that was first synthesized by Bristol-Myers Squibb in 1986. Eptapirone is structurally related to other azapirones like buspirone and ipsapirone.

Pharmacology[edit | edit source]

Eptapirone acts as a full agonist at the 5-HT1A receptor, meaning it can produce the maximum response possible from this receptor. This is in contrast to partial agonists, which can only produce a partial response regardless of the drug dosage. The 5-HT1A receptor is a subtype of the 5-HT receptor that binds the neurotransmitter serotonin, and is involved in a variety of functions including mood, anxiety, and cognition.

Clinical Use[edit | edit source]

Eptapirone has been studied for its potential use in the treatment of anxiety disorders, depression, and other conditions. However, as of 2021, it is not currently approved for medical use in any country.

Chemistry[edit | edit source]

Eptapirone belongs to the azapirone class of compounds, which are characterized by their pyrimidinylpiperazine and furanopyridine moieties. Other azapirones include buspirone, gepirone, and ipsapirone, all of which also act as 5-HT1A receptor agonists.

See Also[edit | edit source]

References[edit | edit source]

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD